This article is more than 5 years old. Information may no longer be current.
FDA clears nonmydriatic retinal camera
Click Here to Manage Email Alerts
LAS VEGAS — Canon unveiled its CR-2 Plus Digital Nonmydriatic Retinal Camera, which has received 510(k) clearance from the Food and Drug Administration, here at International Vision Expo and Conference.
The camera offers all of the capabilities of Canon's CR-2 with the addition of fundus autofluorescence (FAF) photography. FAF can help the practitioner assess and monitor the condition of the retinal pigment epithelial layer, according to a company press release.
The CR-2 Plus is compact and lightweight, delivers both red-free and cobalt digital filters and features a dedicated 18-megapixel EOS camera technology specifically adapted to capture detailed diagnostic images of the retina, a low-flash intensity to minimize pupil constriction, stereo photography, an optional hard shell protective travel case, a joystick that allows for one-handed operability and an illuminated user interface panel for darkly lit rooms, the release said.
Also, the camera is complemented by Canon's retinal imaging control software, which allows images to be captured, processed and sent to a permanent storage database as DICOM2 or JPEG files, according to the release.